Masimo

Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market

Masimo Announces International Availability of Pronto-7-a Palm-sized Spot-Check Device for Noninvasive Total Hemoglobin Measurement

Largest Hospital in the UAE Converts to Pulse CO-Oximetry Technology-Offering Advanced Monitoring of Blood Constituents and Multiple Physiological Parameters Without Invasive Procedures

Network of 53 Hospitals Gain Access to Masimo SET Pulse Oximeters

IRVINE, California, August 24, 2011 - - With Photo - European Availability Expands Access to Critical Care Brain Function Platform Masimo (NASDAQ: MASI) announced today that it has received CE Mark for its SEDLine brain function monitor - expanding access to and availability of SEDLine's advanced neuromonitoring technology to hospitals and clinicians across Europe.

MORE..

IRVINE, California, August 8, 2011 - Masimo (NASDAQ: MASI) today announced CE Mark clearance for the international release of the Masimo Pronto-7-a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb), SpO2, pulse rate, and perfusion index.

MORE..

IRVINE, California and DUBAI, United Arab Emirates, February 10, 2011 - Mafraq Hospital (www.mafraqhospital.ae) and Masimo (www.masimo.com) (Nasdaq: MASI) jointly announced the hospital-wide conversion of Mafraq Hospital to Masimo rainbow(R) SET Pulse CO-Oximetry(TM) technology for advanced noninvasive patient monitoring capabilities.

MORE..

Older News

IRVINE, California, November 18 - Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Lyon, France-based Uni.H.A., one of the largest healthcare Group Purchasing Organizations (GPO) in France, has signed a multi-year purchasing agreement for "gold standard" Masimo SET(R) pulse oximeters.

MORE..